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Panx3Three family members compose the pannexin family of channel-forming glycoproteins (Panx1, Panx2 and
Panx3). Their primary function is deﬁned by their capacity to form single-membrane channels that are reg-
ulated by post-translational modiﬁcations, channel intermixing, and sub-cellular expression proﬁles. Panx1 is
ubiquitously expressed in many mammalian tissues, while Panx2 and Panx3 appear to be more restricted in
their expression. Paracrine functions of Panx1 as an ATP release channel have been extensively studied and
this channel plays a key role, among others, in the release of “ﬁnd-me” signals for apoptotic cell clearance.
In addition Panx1 has been linked to propagation of calcium waves, regulation of vascular tone, mucociliary
lung clearance, taste-bud function and has been shown to act like a tumor suppressor in gliomas. Panx1 chan-
nel opening can also be detrimental, contributing to cell death and seizures under ischemic or epileptic con-
ditions and even facilitating HIV-1 viral infection. Panx2 is involved in differentiation of neurons while Panx3
plays a role in the differentiation of chondrocytes, osteoblasts and the maturation and transport of sperm.
Using the available Panx1 knockout mouse models it has now become possible to explore some of its phys-
iological functions. However, given the potential for one pannexin to compensate for another it seems imper-
ative to generate single and double knockout mouse models involving all three pannexins and evaluate their
interplay in normal differentiation and development as well as in malignant transformation and disease. This
article is part of a Special Issue entitled: The communicating junctions, roles and dysfunctions.
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The pannexin family of channel proteins consists of three members,
namely Panx1, Panx2 and Panx3. This family of integralmembrane pro-
teinswas ﬁrst identiﬁed in themammalian genome in the year 2000 by
Panchin and colleagues [1]. Pannexinswere discovered due to their lim-
ited sequence homology (25–33% identity) to the invertebrate gap
junction proteins, innexins (Inxs) [1,2], and were initially proposed to
share functional features with the vertebrate gap junction proteins,
connexins (Cxs). While no sequence homology exist between Panxs
and Cxs all three families of proteins are predicted to exhibit similar to-
pology with four α-helical transmembrane (TM) domains, two extra-
cellular loops (EL), and one intracellular loop (IL), with their amino
(NT) and carboxyl (CT) termini exposed to the cytoplasm [1–3] (Fig. 1).
Among the pannexin familymembers, theNT region is themost high-
ly conserved domain while the highest sequence variability is found in
the CT domain [2]. Panx1 and Panx3 are more homologous to each
other than to Panx2 [4]. Panx2 exhibits a much larger CT domain that is
speculated to convey unique functions to Panx2 regulation, targeting or
macromolecular interactions [2]. Additionally, Inxs and Panxs have two
cysteine residues in each of their EL domains (Fig. 1) with the exception
of Drosophila Inx4 that has 3 cysteines in each loop [2,5]. On the other
hand, all members of the Cx family (except Cx23 [6]) possess 3 cysteine
residues within each EL which form intramolecular disulﬁde bonds [7].
Analogous to the connexin family of gap junction proteins, initial
characterization of Panx1 oligomerization revealed that 6 subunits
were required to form a channel [8]. However, similar analysis of
Panx2 using a C-terminal truncation mutant revealed that this pan-
nexin most likely assembles into heptamers or octomers [9]. The
ﬁeld is still awaiting an oligomer analysis of Panx3 but given its
close polypeptide sequence relationship to Panx1 it is predicted to
form hexamers. Recently the substituted cysteine accessibility meth-
od was used to identify the pore lining residues of Panx1 channels.
This approach revealed that the outer pore structure of Panx1 is
lined by portions of the ﬁrst TM and ﬁrst EL regions whereas the
inner pore lining is contributed by the CT domain and not the NT as
it is for connexins [10].
Pannexin oligomers are often called pannexons [8] following the
nomenclature established for connexins where oligomers are termed
connexons [11,12]. While ‘connexons’ are also referred to as ‘hemi-
channels’ (i.e. a structure constituting half of a cell–cell channel);
the term ‘pannexons’ refers to single-membrane channels. In fact,
many authors strongly discourage calling pannexons, hemichannels,
as this infers that they are destined to proceed to assemble into an
intercellular channel which is not well supported by many recent
publications as reviewed by Sosinsky and colleagues [13].
We and others have reported that Panx1 is projected to have a
very long half-life [4,14]. The cell surface population of Panx1
remained relatively unchanged when protein secretion was blocked
with brefeldin A (BFA) suggesting that this pannexin was not subject
to rapid displacement and renewal [4]. In fact, it took up to 32 h of
BFA treatment before some clearing of Panx1 from the cell surface
was evident with a concomitant increase in newly synthesized
Panx1 localized to an ER-like pattern, while clearing of Cx43 fromthe cell surface was evident within 3 h of BFA treatment (Fig. 2A).
This eventual clearing of Panx1 from the cell surface was further cor-
related with a reduction in the highly glycosylated Gly2 species and
an increase in the high-mannose Gly1 species of Panx1 after 20 h of
BFA treatment (Fig. 2B). Further evidence that Panx1 is a long-lived
molecule was provided as there was a negligible change in the
Panx1 species banding pattern upon BFA washout (Fig. 2B).
2. Pannexin expression and genomics
In addition to the human and mouse genomes, the expression of
all three pannexin members has now been identiﬁed in at least 5
more species including: Rattus norvegicus (rat), Canis familaris
(dog), Bos taurus (cow), Danio rerio (zebraﬁsh) and Tetraodon nogro-
virdis (puffer ﬁsh) [2]. Despite the vast inter-species distribution,
pannexins are most well characterized in human and murine tissues.
Overall, the human PANX1 (accession number NP_056183, 426
amino acids, 47.6 kDa), PANX2 (accession number NP_443071, 677
amino acids, 74.4 kDa) and PANX3 (accession number NP_443191,
392 amino acids, 44.7 kDa) have conserved sequence homologies of
up to 94% with murine pannexins [15].
2.1. Pannexin1 (Panx1)
Various levels of Panx1 are ubiquitously expressed in human tis-
sues such as the brain, heart, skeletal muscle, skin, testis, ovary, pla-
centa, thymus, prostate, lung, liver, small intestine, pancreas, spleen,
colon, blood endothelium and erythrocytes, as it was initially reported
by Northern blot analysis [3]. Speciﬁcally in the central nervous sys-
tem Panx1 transcripts were detected in the cerebellum, cortex, lens
(ﬁber cells), retina (retinal ganglion, amacrine and horizontal cells),
pyramidal cells, interneurons of the neocortex and hippocampus,
amygdala, substantia nigra, olfactory bulb, neurons and glial cells
[3,16–26]. At the protein level, a tissue survey using custom-
designed afﬁnity puriﬁed anti-Panx1 antibodies revealed a robust ex-
pression of Panx1 in the brain, with variable levels of Panx1 in the
lung, kidney, spleen, heart ventricle, skin and sources of cartilage
from the ear and tail of 3-week oldmice [4]. More recently, Panx1 pro-
tein expression was also detected in the rodent cochlea, speciﬁcally in
supporting cells of the organ of Corti, spiral limbus, cochlear lateral
wall, strial blood vessels [27] and in vascular smooth muscle cells of
thoracodorsal arteries [28]. In addition, Panx1 has also been reported
in the basal compartments of the seminiferous epithelium and epidid-
ymis, and in the apical region of efferent ducts of adult rats [29].
2.2. Pannexin2 (Panx2)
In comparison to Panx1, Panx2 mRNA appears more restricted to
several areas of the human adult brain including: cerebellum, cerebral
cortex, medulla, occipital pole frontal lobe, temporal lobe and putamen
[3]. While Northern blot analysis revealed high levels of Panx2 tran-
script in the rodent brain, spinal cord and eyes, other tissues such as
thyroid, kidney and liver revealed low levels of Panx2 transcripts
[16–18]. Interestingly, in situ hybridization revealed co-expression of
Fig. 1. Schematic representation of the three pannexin family members. Panx1 (426)
Panx2 (677) and Panx3 (392) of varying amino acid lengths are all tetra-spanning in
tegral membrane proteins with N-glycosylation sites at amino-acid 254 (Panx1), 86
(Panx2, predicted), and 71 (Panx3). Panx1 and Panx3 are glycosylated to both a
high-mannose form and a complex glycoprotein, while Panx2 has only been reported
as a high-mannose glycoprotein or a palmitoylated isoform. All pannexins have two
cysteine residues in each extracellular loop (C). Panx1 has been shown to oligomerize
into a hexamer to form single-membrane channels at the cell surface ofmanymammalian
cells. EL1, EL2 (extracellular loops 1 and 2), IL (intracellular loop), CT (carboxy-terminus
and NT (amino-terminus).
17S. Penuela et al. / Biochimica et Biophysica Acta 1828 (2013) 15–22,
-
)Panx2 with Panx1 in various regions of the adult rat brain, such as hip-
pocampus, olfactory bulb, pyramidal cells, dentate gyrus, Purkinje cells
of the cerebellum, pyramidal cells and interneurons of the hippocampus
and neocortex [23]. Unlike Panx1, low levels of Panx2 transcripts were
detected in the prenatal brain while transcript levels substantially
increased in postnatal brains [23]. Recently, Panx2 protein expression
was identiﬁed in the basal cells of the stria vascularis and spiral ganglion
neurons of the rat cochlear system [27], as well as in neural stem and
progenitor cells of the mouse hippocampus [30].2.3. Pannexin3 (Panx3)
Based on expressed sequence tags, Panx3 was found in osteoblasts,
synovial ﬁbroblasts, whole joints of mouse paws and cartilage from the
inner ear [3]. In addition, low levels of Panx3 transcripts were detected
in human hippocampus extracts [3]. Panx3 protein was reported in mu-
rine cochlear bone [27]while in situ hybridization of embryonic day 16.5
mice strongly revealed Panx3 expression in prehypertrophic chondro-
cytes, perichondriumand osteoblasts [31]. Furthermore,we demonstrat-
ed that while Panx3 protein exhibits two forms at ~43 kDa and ~70 kDa
in skin, cartilage, and ventricle only the ~70 kDa species was detected in
lung, liver, kidney, thymus and spleen of 3 week old mice [4]. It is how-
ever yet to be determined if the occurrence of the ~70 kDa immunoreac-
tive species is due to Panx3 dimerization. Panx3 has also been shown to
be endogenously expressed in osteoblasts, both in primary culture from
murine calvaria and in reference cell lines [32–34]. Recently, Panx3 was
also reported to be present in Leydig cells, the epididymis and efferent
ducts of adult rats [29]. Overall, endogenous Panx1, Panx2 and Panx3expression has been identiﬁed in a number of cultured reference cell
lines as summarized in Table 1.3. Biochemistry of pannexins
3.1. Post-translational modiﬁcations of pannexins
Panx1 and Panx3 protein sequence analysis followed by site-
directed mutagenesis revealed that N-linked glycosylation occurs at
asparagine 254 in the second extracellular loop of Panx1, and at as-
paragine 71 in the ﬁrst extracellular loop of Panx3 [4] (Fig. 1). N-
glycosidase F and endoglycosidase H (Endo H) enzymatic digestion
studies conﬁrmed the glycosylation status of Panx1 and Panx3
[4,8,15]. Three distinct species of Panx1 and Panx3 were revealed:
the non-glycosylated core species— Gly0, the predominant endoplas-
mic reticulum (ER) resident high mannose species — Gly1 and the
complex glycosylated species — Gly2. In addition, Panx2 also encodes
a potential N-linked glycosylation consensus site in its ﬁrst EL domain
at asparagine 86 but glycosylation of this residue has yet to be con-
ﬁrmed by a site-directed mutagenesis study [15] (Fig. 1). However,
Endo H digestion supports the premise that Panx2 is glycosylated to
a high mannose species [15]. Glycosylation of Panx1 and Panx3 was
found to be important for proper trafﬁcking of these pannexins to
the cell surface. This conclusion is based on reduced [4] or absent
[8] cell surface localization of the glycosylation-deﬁcient mutants
Panx1N254Q or Panx3N71Q. Nevertheless, the population of N-
glycosylation-deﬁcient Panx1 and Panx3 mutants that do reach the
cell surface are functional in their ability to uptake dye [15] thus indi-
cating that these pannexins can form functional channels even in the
absence of glycosylation.
Interestingly, in another study Endo H treatment did not alter the
mobility of Panx2, rather the ~80 kD species observed in neural pro-
genitor cells was found to be sensitive to hydroxylamine suggesting
Panx2 was palmitoylated [30]. Although Panx2 does not contain a
clear palmitoylation consensus sequence, the in silico analysis
revealed a potential site (SYLCTYY) at residue 246 [30]. Further site-
directed mutagenesis studies will be necessary to conﬁrm the palmi-
toylated status of Panx2.3.2. Pannexin intermixing
Panx family members share signiﬁcant sequence homology and
have been reported by us and others to interact and form potential
intermixed channels [15,35]. This intermixing is more evident be-
tween Panx1 and Panx2 and is governed by their level of N-
glycosylation, as only the core and high-mannose species of Panx1
co-immunoprecipitate with Panx2. Panx1 and Panx3 interact to a
lesser extent with no observed change to the channel function
while channels are attenuated when Panx1 and Panx2 intermix
[15,35]. However, since Panx1 forms hexamers while Panx2 is pro-
posed to form octomers it is difﬁcult to speculate what type of oligo-
mer occurs when Panx1 and Panx2 intermix. Ambrosi et al. [9]
recently attempted to address this question by purifying Panx1/
Panx2 heteromeric channels. However, the isolated channels were
found to be unstable. These authors also observed a reduction in cur-
rent when Panx1 and Panx2 were co-expressed in Xenopus oocytes
indicating a mutual inhibition between these pannexins. It was fur-
ther postulated that due to the formation of unstable heteromeric
channels it is possible that they do not co-oligomerize in vivo. Given
the known physical interaction between Panx1 and Panx2 it is possi-
ble that this interaction causes them to mis-trafﬁc or mis-fold. [9].
There is no evidence for Panx2 and Panx3 intermixing at the bio-
chemical level [15] and they have not been reported to be co-
expressed in the same cell types.
Fig. 2. Panx1 is a long-lived protein compared to Cx43. Long-term brefeldin-A (BFA) treatment of BICR-M1Rk rat mammary tumor cells revealed a clearing of the cell surface pop-
ulation of exogenously expressed Panx1 and the accumulation of an intracellular pool of Panx1 after 32 h of BFA treatment. On the other hand there was a clearing of cell surface
Cx43 as early as 3 h post-BFA treatment. Anti-Panx1 (CT-395) and anti-Cx43 antibody labeling are shown in red. Nuclei (blue) are stained with Hoechst 33342. Bars, 10 μm (A).
Western blotting for Panx1 revealed an accumulation of the high mannose species of Panx1 (Gly1) with a noticeable reduction in the higher molecular weight glycosylation species
(Gly2) after 20 h of BFA treatment. GAPDH was used as a loading control (B). Results shown are representative of three independent experiments.
Table 1
Reference cell lines reported to endogenously express pannexins. Endogenous pan-
nexin expression reported in cultured cell lines by RT-PCR (mRNA level, “r”) or West-
ern blot (protein, “p”) as speciﬁed in the corresponding references. Note that many of
these cells lines have only been shown to express pannexin mRNA andmay not express
detectable levels of pannexin protein.
Cultured cell line Panx1 Panx2 Panx3
Mouse neuroblastoma— N2A [30]r, p
Mouse pituitary cells — AtT-20 [76]r, p [76]r, p
Mouse osteoblast — MC3T3-E1 [4]p [32,34]r, p
Mouse chondrogenic — ATDC5 and N1511 [31]r, p
Mouse osteoprogenitor — C2C12 [33]r, p
Mouse macrophage — J774 [44]r
Rat epidermal keratinocyte — REK [54]p
Canine kidney — MDCK [8,34]p [34]p
Human bronchial epithelial — WD-HBE [73]r
Human cervical-HeLa S3 cells
(ATCC number CCL-2.2); HeLa
[18,77]r, p
Human prostate cell — LNCaP [57]r
Human kidney-HEK293 [57,77]r
Human monocyte-THP-1 [77]r
Human Jurkat T cells [42]r, p
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In addition to the protein–protein interactions described among
pannexin family members new members are being added to the pan-
nexin interactome. Panx1 was shown to interact with actin and this
interaction was demonstrated to be direct and involves the Panx1
C-terminal tail. It has been proposed that Panx1 depends on actin mi-
croﬁlaments for proper trafﬁcking and stability at the plasma mem-
brane [36]. In another study, a bacterial two-hybrid system was
used to identify the potassium channel subunit Kvβ3 as a potential
interacting partner of Panx1 [37]. This interaction was later con-
ﬁrmed by co-immunoprecipitation experiments in neuroblastoma
cells where Kvβ3 was further proposed to be involved in the regula-
tion of Panx1 channel sensitivity to redox potentials [38]. In another
study, α1D-adrenergic receptors were reported to interact with
Panx1 in mouse thoracodorsal resistance arteries [28]. Panx1 was fur-
ther shown to play a role in phenylephrine-induced vasoconstriction
of resistance arteries through this association with α1D-adrenergic
receptors [28]. Finally, Panx1 was found to also interact with several
components of the multiprotein inﬂammasome complex including
the P2X7 receptor, caspase-1, caspase-11, NLRP1, ASC, and the inhib-
itor of apoptosis XIAP [39]. Further studies should deﬁne what role
Panx1 plays in the function of the inﬂammasome.
4. Channel functions of pannexins
In 2003, it was reported that Panx1 has the ability to form non-
junctional membrane channels in single Xenopus oocytes [16]. Later,
the unitary conductance of Panx1 channels was determined to be550 pS [40], which was approximately 200 pS larger than that of
any of the connexins [41]. Since these early studies, we and others
have reported that all pannexins can form channels capable of dye
uptake [15]. Although Panx2 was initially reported to be incapable
of forming functional single membrane channels [16], a recent study
using a cytochrome c based proteoliposome assay as well as electro-
physiological recordings in Xenopus oocytes revealed that Panx2 can
19S. Penuela et al. / Biochimica et Biophysica Acta 1828 (2013) 15–22form functional homomeric channels that open at high voltages [9].
Functional single membrane channels composed of homomeric
Panx3 were also proposed to play a role in ATP release into the extra-
cellular space and act as Ca2+ channels in the ER of C2C12 cells and
primary calvarial osteoblasts [33]. However, electrophysiological evi-
dence for Panx3 homomeric channel function has yet to be reported.
While Panx1 channels can be activated by mechanical stimulation,
caspase cleavage, cytoplasmic Ca2+, membrane depolarization, extra-
cellular ATP and K+ [39,40,42–46]; its ability to function is abolished
by CO2-mediated cytoplasmic acidiﬁcation [43], negative feedback
from ATP release [47], mimetic peptides [48] and channel blockers
such as carbenoxolone, probenecid and ﬂuefenamic acid [49,50]. It
is now quite well established that the activation of pannexin channels
allows for cellular communication with the extracellular environment
to fulﬁll a diverse range of functions [43,51–54].
Currently, there are conﬂicting reports in the literature as to
whether pannexins are ever involved in direct intercellular commu-
nication. It was initially reported that the expression of Panx1, but
not Panx2 or Panx3 in paired Xenopus oocytes led to intercellular
channels, albeit, 24–48 h after cell pairing [16,35,55]. In a parallel
study, Boassa et al. [8] reported that Panx1 intercellular channels
did not form under similar conditions while robust Cx46 intercellular
channels readily assembled [8]. To date two other laboratories have
provided some evidence that Panx1 forms intercellular channels
when overexpressed in C6 glioma cells [56] and LNCaP prostate can-
cer epithelial cells [57]. Also, Panx3 was recently reported to form gap
junctions in osteoblasts [33]. However, these latter studies revealing
the passage of sulfurodamine 101 dye in C6 gliomas [56] and Ca2+
permeability in LNCaP neighboring cells [57] or osteoblast cells [33]
were all performed under very speciﬁc conditions raising questions
as to whether background levels of connexins may have contributed
to the evidence that intercellular channels had indeed formed. Evi-
dence against pannexins forming intercellular channels continues to
grow as a dye transfer assay in Panx1-enriched and connexin nega-
tive Madin–Darby Canine Kidney cells failed to reveal the presence
of intercellular channels [8]. This study was in line with our ﬁndings
that revealed no electrical coupling in gap junction-deﬁcient neuro-
2A cells expressing either Panx1 or Panx3 [4]. Additional reports in-
volving erythrocytes [58] as well as neuronal and glial cells [52]
have also failed to provide evidence that pannexins can in fact form
intercellular channels thus providing further indications that the pan-
nexin family of proteins does not likely serve a redundant role to con-
nexins by forming intercellular channels [13]. Finally, it is notable that
there remains no in vivo evidence for the existence of pannexin-
based intercellular channels.
4.1. Paracrine signaling mediated by Panx1
Indirect communication between cells is typically mediated
through activation of single-membrane channels and the releasing
of molecules such as ATP [59] into the extracellular space.
4.1.1. Calcium waves
Ca2+ is a versatile, ubiquitously found second messenger that can
regulate several cellular responses [60]. Initiation of Ca2+ waves is
mediated by the activation of ATP-sensitive purinergic receptors,
P2Y and P2X [61]. Binding of ATP to the P2Y receptors increases inosi-
tol 1,4,5-triphosphate, which in turn releases Ca2+ from the ER
stores. Once released, Ca2+ activates single-membrane channels
leading to further release of ATP and propagation of signals to neigh-
boring cells [49]. Essential to this notion is the fact that Panx1 has
been shown to be a part of the P2X7 receptor complex necessary for
ATP release [44,58,62]. Furthermore, ATP-induced ATP release was
also reported when Panx1 channels were activated through P2Y re-
ceptors and cytoplasmic Ca2+ [43], thus supporting the role of
Panx1 in the initiation and propagation of regenerative Ca2+signaling. The interaction of Panx1 channels with NMDA receptors
has also been shown to participate in the regulation of Ca2+ in hippo-
campal pyramidal neurons and is proposed to play a role in epilepsy
[53]. The role of Panx1 in epilepsy was recently conﬁrmed in vivo
using Panx1 null mice [63].
4.1.2. Vasodilation and vasoconstriction
Release of ATP from erythrocytes occurs during stress and hypoxic
conditions [64]. It was reported that erythrocytes endogenously ex-
press Panx1 and mechano-sensitive activation of Panx1 channels reg-
ulates ATP release [58]. It is hypothesized that under conditions of
stress activation, Panx1 channels control blood ﬂow by releasing
ATP from red blood cells and initiating Ca2+ wave propagation
through the stimulation of purinergic receptors on the endothelial
cells [58]. Elevation of Ca2+ subsequently releases NO onto the
smooth muscle leading to vasodilation [58]. Recently, Billaud et al.
[28] showed that Panx1 is expressed in both endothelial and vascular
smooth muscle cells (VSMC) and plays a key role in phenylephrine-
induced vasoconstriction of resistance arteries through an association
between Panx1 and α1D-adrenergic receptor in VSMCs. This indi-
cates that Panx1 may be directly linked to the coordination of vascu-
lar smooth muscle cell constriction and potentially the regulation of
blood pressure.
4.1.3. Taste sensation
Taste buds are comprised of two distinct populations of cells, some
that express taste receptors (receptor cells) and others that contain
synapses (presynaptic cells) [65]. It has been reported that Panx1 is
expressed in the receptor cells and upon taste stimulation ATP is re-
leased through Panx1 channels [50,65]. Once released in the extracel-
lular medium, ATP stimulates P2 receptors of the presynaptic cells to
release serotonin (5-HT) [50,65] thereby providing a mechanism for
cell–cell signaling and information processing within the taste bud.
4.1.4. Airway defense
Airway epithelium provides a defense mechanism by controlling
mucociliary clearance which depends on maintaining adequate air-
way surface liquid volume and ciliary activity [66]. In the differentiat-
ed human airway epithelium, expression of Panx1 channels has been
linked to ATP release under hypotonic stress [66]. Panx1-evoked ATP
release is proposed to be crucial for regulating the ciliary beat fre-
quency and surface liquid volume for mucous clearance [66].
4.1.5. Viral infection
ATP release by Panx1 channels has also been reported to play a
role in HIV-1 viral infection of CD4+ cells [67]. HIV-1 envelope pro-
teins are proposed to interact with speciﬁc CD4+ cell receptors and
trigger the release of ATP via Panx1 channels into the extracellular
milieu where ATP then acts on P2Y2 purinergic receptors and acti-
vates Pyk2 kinase. This interaction causes membrane depolarization
and facilitates membrane-to-membrane fusion to allow viral entry
into the cell as well as cell-to-cell transmission. Interestingly, Panx1,
P2Y2 and Pyk2 are all physically recruited to the contact site between
Env-containing and CD4/CDXCR4-containing membranes indicating
that they form part of the infection synapse that is orchestrated by
the virus to facilitate infection [67]. Inhibiting any of the components
of this interaction could reduce HIV-1 infection and impair viral rep-
lication indicating their potential use as a novel antiretroviral
therapy.
4.2. Cellular responses mediated by Panx1
4.2.1. Immune response
Interaction of Panx1 with P2X7 receptors elicits an immune re-
sponse by releasing the pro-inﬂammatory cytokine interleukin (IL)-1
β in response to receptor stimulation by ATP followed by a subsequent
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like receptor-independent inﬂammasome (comprising cryopyrin)
based on recognition of bacterial molecules passing from endosomes
to cytosol [68]. Furthermore, P2X7-mediated activation of Panx1 chan-
nels was found to be potentiated by high extracellular K+ levels in neu-
ronal/astrocytic inﬂammasomes [39]. However, in a recent study using
Panx1 null mice [69] the authors found that Panx1 is not required for
the assembly of caspase-1-activating inﬂammasome complexes.
4.2.2. Tumorigenesis
Exogenous expression of Panx1 has been linked to tumor-
suppressive properties in C6 gliomas [56]. In the presence of Panx1,
C6 gliomas exhibit a ﬂattened morphology and a reduction in prolif-
eration, motility and anchorage-independent growth [56]. In addition,
Panx1 overexpressing cells exhibited reduced in vivo tumor growth in
nude mice as compared to controls [56]. Taken together, it is suggested
that Panx1 plays a role as a tumor suppressor. Later, these same authors
reported a similar tumor suppressive role for Panx2 [70].
4.2.3. Ischemic cell death and epileptic seizure
The rapid decrease of O2 and glucose in mouse hippocampal pyra-
midal neurons has been associated with the opening of Panx1 chan-
nels that lead to conductance of large currents [71]. This, in turn,
causes a profound ionic dysregulation leading to neuronal death
[71]. In addition, the N-methyl-D-aspartate receptor-based opening
of Panx1 channels augments epileptiform seizure activities in pyrami-
dal neurons [53] further supporting the importance of precise regula-
tion of Panx1 channel opening. As will be discussed later, studies
using Panx1 knockout mice have now conﬁrmed that Panx1 contrib-
utes to the severity of epileptic seizures in vivo [63].
4.2.4. Apoptosis
Panx1 has been proposed to form the pore unit of the P2X7 death
complex [62]. The co-expression of Panx1 with P2X7 receptor
revealed ATP-induced zeiosis in Xenopus oocytes which was not ob-
served upon the injection of Panx1 transcript alone or together with
P2Y receptor [43,62]. These results suggest that although activation
of the purinergic P2Y receptor canmediate Panx1 currents, the specif-
ic cell death signaling is through an interaction with ionotropic P2X7
receptors. Quite recently, Panx1 channels have been documented to
mediate the release of nucleotide signals from apoptotic cells for the
recruitment of activated monocytes [42]. Mechanistically, the authors
showed that Panx1 channels get activated by caspases which cleave
Panx1 and open the channel for ATP and UTP release as a “ﬁnd me”
signal to attract phagocytes [42].
4.2.5. Keratinocyte differentiation
We have previously shown that ectopically expressed Panx1 re-
duces the proliferation rate of rat epidermal keratinocytes (REKs),
however, it does not signiﬁcantly alter their migratory properties
[54]. Furthermore, over-expression of Panx1 in organotypic cultures
(generated from monolayer REKs) disrupts the overall architecture
of the epidermis, reduces the thickness of the living cell layer and
re-localizes the basal cell marker, cytokeratin 14, throughout the liv-
ing cell layer [54]. Thus, this study argues for a role of Panx1 in the
regulation of keratinocyte differentiation.
4.3. Cellular responses mediated by Panx2 and Panx3
4.3.1. Neuronal differentiation
Swayne et al. [30] demonstrated that Panx2 is expressed by progen-
itor neural cells as well as mature neurons. However, this expression is
post-translationally regulated by the generation of S-palmitoylated
Panx2 species that appear to be localized within intracellular compart-
ments of stem-like neural progenitor cells, but not in mature neurons.
Following maturation, neurons were shown to re-express Panx2 atthe plasma membrane. Additionally, the authors found that Panx2
knockdown in Neuro2a cells signiﬁcantly accelerated the rate of neuro-
nal differentiation [30].
4.3.2. Differentiation and development
In contrast to Panx1, much less is known about the channel capa-
bilities of Panx3. We have shown that, similar to Panx1, Panx3 also re-
duces the proliferation of REKs without altering their migration rates
[54]. However, unlike Panx1, Panx3 maintains the integrity of the
organotypic epidermis and keratinocyte differentiation upon its
over-expression [54]. In addition, Panx3 expression in cartilage has
recently been associated with chondrocyte differentiation [31]. Spe-
ciﬁcally, Panx3 was found to promote ATP release into the extracellu-
lar medium and reduce the parathyroid hormone-mediated
proliferation of chondrocytes by decreasing cAMP levels and inhibit-
ing phosphorylation of CREB [31]. Thus, these results support a role
for Panx3 in switching the properties of chondrocytes from prolifera-
tion to differentiation. Two recent reports further highlight the role of
Panx3 in chondrocyte/osteoblast differentiation where the Panx3
promoter was found to be responsive to Runx2 activation [32] and
may function as an ER calcium channel, plasma membrane channel
or even as a gap junction [33]. It is notable that Panx3 expression
caused a concomitant increase in Cx43 leaving one to wonder if the
gap junction function was due to this connexin and not due to
Panx3. Recently, Panx3 was also reported to be present in rat Leydig
cells, the apical region of the epididymis and in efferent ducts raising
the possibility that Panx3 plays a role in sperm transport and matura-
tion [29].
5. Pannexin knockout mice as models for determining the physio-
logical roles of pannexins
As a result of the increased interest in uncovering the physiologi-
cal roles of pannexins, several groups have now generated Panx1
knockout mouse models (Panx1-KO). Surprisingly, given the ubiqui-
tous expression of Panx1 in many human and mouse tissues most au-
thors report no major abnormalities in the anatomy and overall
health of the Panx1 knockout mice. One of the ﬁrst published reports
of a Panx1 knockout mouse was provided by Anselmi et al. [72] using
a mouse generated by Hannah Monyer's laboratory in Germany. In
that study, Panx1-KO-derived cochlear organotypic cultures were
used to show that the ATP-induced intercellular Ca2+ signal propaga-
tion was due to Cx26 and Cx30 hemichannels and did not involve
Panx1 channels [72]. The same Panx1-KO mouse was acquired by
Santiago et al. [63] along with a heterozygote Panx1-knockout ‘(KO)
ﬁrst’ mouse generated by the knockout mouse project (KOMP) at
the University of California-Davis. These two mouse models were
used to demonstrate that Panx1 channels contribute to status epilep-
ticus in vivo by increasing the severity and duration of seizures [63].
This data is consistent with previous reports of Panx1 channel open-
ing in hippocampal neurons exposed to NMDA potentiating seizure-
like activity [53]. A third Panx1-KO mouse also derived from embry-
onic stem cells obtained from KOMP was used by Seminario-Vidal
[73] to test the hypothesis that Panx1 mediates ATP release from
hypotonically swollen airway epithelia as was reported in vitro by
Ransford et al. [66]. Using primary cultures of bronchial epithelial
cells as well as freshly excised tracheas from Panx1-KO mice they
saw a signiﬁcant reduction in the hypotonicity-induced ATP release
as well as dye uptake indicating a key role for Panx1 channels in the
airway epithelia [73]. Finally, a fourth Panx1-KO mouse was generat-
ed by Genentech Inc. and used to discover that, contrary to previous
reports, Panx1 is not required for inﬂammasome activation but it is
needed for the release of chemoattractants as “ﬁnd-me” signals for
phagocytic cells for appropriate apoptotic cell clearance as was earlier
described by Chekeni et al. [42]. Interestingly, these authors also
demonstrated that ATP engagement of the P2X7 receptor increases
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belong to distinct signaling pathways [69].
Given the apparent normal morphology and physiology of Panx1
KO mice that are not under stress or harboring an additional pathol-
ogy, it is possible that compensation by other members of the pan-
nexin family could be at play. A recent study on cerebral ischemia
using either single (Panx1−/−or Panx2−/−) or double knockout
(Panx1−/− Panx2−/−) mice revealed that only the double knockout
mice had a signiﬁcant effect on the function of cortical neurons [74].
The ablation of just one of the pannexins had no effect but the double
knockout mouse had smaller infarcts than the control mice during is-
chemic stroke [74]. This raises the possibility that double or triple
pannexin knockout mice may be needed in future studies to resolve
the physiological roles of pannexins in different cellular systems. Ad-
ditionally, since connexin hemichannels have been postulated to
carry out similar ATP release and paracrine signaling functions [75]
as pannexin channels, it will also be important to assess any potential
cross-talk between the pannexin and connexin families of channel-
forming proteins using combinations of pannexin and connexin
knockout mouse models.6. Conclusion
The initial interest in the pannexin family of proteins was derived
from their limited homology to the innexin family of gap junction pro-
teins. Consequently, they were ﬁrst thought to be a third family of gap
junction proteins with similar tetra-spanning topologies but very di-
verse sequences. With the exception of a few reports in which Panx1
and Panx3 were suggested to form intercellular gap junction channels,
the vast majority of the literature supports what is thought to be their
primary role in forming single membrane channels. These channel
forming glycoproteins are all capable of dye uptake and Panx1 has
been extensively reported as an ATP/UTP release channel even under
conditions of physiological levels of calcium. Post-translational modiﬁ-
cations appear to regulate their expression, intracellular localization,
intermixing and perhaps their ultimate function in different tissues.
We are only beginning to uncover the interesting physiological roles
that pannexinsmay play as independent channels necessary for normal
paracrine signaling, regulation of differentiation and cell death, and im-
mune function. Evidence suggests that they are involved in pathologies
possibly as potential tumor suppressors or ischemic cell-death and sei-
zure enhancers. With the arrival of more single and double Panx-KO
mouse models that will allow for compensatory mechanisms to be
assessed, the ﬁeld will continue to further elucidate the true nature of
pannexin channels and their key roles in health and disease.Acknowledgements
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